Screener
NeoGenomics NEO EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from NeoGenomics’s reported figures.
Based on trailing twelve months.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
FAQ
- What is NeoGenomics's EBITDA margin?
- NeoGenomics (NEO) reported EBITDA margin of -0.8% in Q2 2026.
- How has NeoGenomics's EBITDA margin changed year-over-year?
- NeoGenomics's EBITDA margin increased by 87.7% year-over-year, from -6.4% to -0.8%.
- What is the long-term trend for NeoGenomics's EBITDA margin?
- Over 4 years (2021 to 2025), NeoGenomics's EBITDA margin has grown at a -16.4% compound annual growth rate (CAGR), from -13.5% to -6.6%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about NeoGenomics's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude